This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jurevic, R. J. Articles by Dale, B. A. Search for Related Content PubMed PubMed Citation Articles by Jurevic, R. J. Articles by Dale, B. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2003, p. 90-96, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.90-96.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Single-Nucleotide Polymorphisms (SNPs) in Human ß-Defensin 1: High-Throughput SNP Assays and Association with Candida Carriage in Type I Diabetics and Nondiabetic Controls

Departments of Oral Biology and Oral Medicine,¹ Pathobiology,³ Biochemistry and Medicine/Dermatology, University of Washington,⁵ Seattle Biomedical Research Institutes, Seattle, Washington,⁴ Albany Molecular Research Inc., Bothell, Washington²

Received 25 July 2002/ Returned for modification 11 September 2002/ Accepted 5 October 2002

ß-Defensins are cationic antimicrobial peptides expressed in epithelia. They exhibit antibacterial, antifungal, and antiviral properties. Defensins are a component of the innate immune response, and it has been proposed that they have a protective role in the oral cavity. Previous studies have shown that human ß-defensin 1 (hBD-1) is constitutively expressed in oral epithelial cells but that expression varies between individuals. We tested the hypothesis that genetic variations in defensin peptide expression may be associated with opportunistic infections. This may be critical in the immunocompromised patient population, in which innate immune responses may have a relatively more important role. Oral Candida carriage status and the presence of six single-nucleotide polymorphisms (SNPs) in the DEFB1 gene encoding hBD-1 were evaluated in type I diabetic patients (n = 43) and nondiabetic controls (n = 50). Genomic DNA was obtained from buccal swabs. Portions of the DEFB1 gene were amplified, and each SNP was analyzed by a TaqMan assay, standardized with control DNA of known genotype. Candida carriage status was determined from unstimulated saliva on CHROMagar plating medium. A low level of Candida carriage was defined as 350 CFU/ml. A high level of Candida carriage was seen in 44% of the diabetic subjects but only in 28% of the nondiabetic controls (P < 0.05). C. albicans predominated; however, diabetic subjects, especially those with high levels of carriage, showed an increased proportion of Candida glabrata and C. tropicalis. There was a strong association between an SNP in the 5' untranslated region (CG at position -44) and Candida carriage in both groups. Among individuals in the diabetic population who had the SNP allele 2 (G), 58% had low CFU, while 6% had high CFU. The CG SNP at position -44 is associated with low levels of Candida carriage. The resultant odd ratios are statistically significant for a protective effect (odd ratios, 25 for diabetic subjects and 8.5 for nondiabetic subjects). These results indicate that genetic variations in the DEFB1 gene encoding hBD-1 may have a major role in mediating and/or contributing to susceptibility to oral infection.

This article has been cited by other articles:

• Diamond, G., Beckloff, N., Ryan, L.K. (2008). Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences. J. Dent. Res. 87: 915-927 [Abstract] [Full Text]  
• Carter, J., Churchill, A. J, Gorman, C., Haynes, R. (2007). A case of bilateral endophthalmitis and carriage of {beta}-defensin 1 44CC genotype. Br. J. Ophthalmol. 91: 1249-1250 [Full Text]  
• Li, L., Redding, S., Dongari-Bagtzoglou, A. (2007). Candida glabrata, an Emerging Oral Opportunistic Pathogen. J. Dent. Res. 86: 204-215 [Abstract] [Full Text]  
• Ray, D., Goswami, R., Banerjee, U., Dadhwal, V., Goswami, D., Mandal, P., Sreenivas, V., Kochupillai, N. (2007). Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis. Diabetes Care 30: 312-317 [Abstract] [Full Text]  
• Tao, R., Jurevic, R. J., Coulton, K. K., Tsutsui, M. T., Roberts, M. C., Kimball, J. R., Wells, N., Berndt, J., Dale, B. A. (2005). Salivary Antimicrobial Peptide Expression and Dental Caries Experience in Children. Antimicrob. Agents Chemother. 49: 3883-3888 [Abstract] [Full Text]  
• Mustapha, S., Sellers, E., Dean, H. (2005). Are children with type 1 diabetes immunocompromised?. CMAJ 173: 341-341 [Full Text]  
• Feng, Z., Jiang, B., Chandra, J., Ghannoum, M., Nelson, S., Weinberg, A. (2005). Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans. J. Dent. Res. 84: 445-450 [Abstract] [Full Text]  
• Boniotto, M., Hazbon, M. H., Jordan, W. J., Lennon, G. P., Eskdale, J., Alland, D., Gallagher, G. (2004). Novel Hairpin-Shaped Primer Assay To Study the Association of the -44 Single-Nucleotide Polymorphism of the DEFB1 Gene with Early-Onset Periodontal Disease. CVI 11: 766-769 [Abstract] [Full Text]  
• Chung, W. O., Dale, B. A. (2004). Innate Immune Response of Oral and Foreskin Keratinocytes: Utilization of Different Signaling Pathways by Various Bacterial Species. Infect. Immun. 72: 352-358 [Abstract] [Full Text]  
• Dale, B. A. (2003). Fascination with Epithelia: Architecture, Proteins, and Functions. J. Dent. Res. 82: 866-869 [Full Text]